SCI Foundation is now Unlimit Health. Learn more about what the change means for our ongoing efforts to eliminate neglected tropical diseases
We aim to constantly improve and innovate, to ensure that we optimise our efforts and use resources most cost-effectively. That’s why our scientists generate evidence to inform decisions and guide our work. By doing this, we’re able to continually better and share our knowledge, ensuring that everyone can benefit from improved health.
In 2022, Unlimit Health was awarded the status of Independent Research Organisation (IRO) by UK Research and Innovation (UKRI), the body responsible for convening the UK’s research councils and for supporting research, knowledge exchange and innovation.
This is an important step in Unlimit Health’s commitment to operate as an evidence-based organisation and enhance our dedication to academic research and programmes that reflect the needs and priorities of our partners.
Developing a suitable formulation to treat infants and preschool-aged children affected by schistosomiasis.
Determining the optimal sampling approach to assess the prevalence of schistosomiasis and guide treatment decisions.
Improving adolescent girls’ and women’s health by reducing morbidity associated with female genital schistosomiasis (FGS).
A community-driven approach to plan environmental and behavioural actions to reduce the transmission of schistosomiasis.
Understanding the impact of existing schistosomiasis control programmes on pork tapeworm (Taenia solium) in Uganda.
Integrating preventive treatment for female genital schistosomiasis into the national health system.
UK Aid working to fight neglected tropical diseases (NTDs) in West and Central Africa.
Identifying meaningful and measurable targets for the control of schistosomiasis-related morbidity in Africa.
Enhancing access to treatment for neglected tropical diseases among refugee populations.
A method to evaluate and tackle concerns with official population data within NTD programmes.